Multiple-Gene Regulation for Enhanced Antitumor Efficacy with Branch-PCR-Assembled TP53 and MYC Gene Nanovector
Multiple proteins are involved in network regulation through the crosstalk of different signaling pathways in cancers. Here, we propose a novel strategy of genome therapy with branch-PCR-assembled gene nanovectors to perform network-based gene regulation at multiple levels for cancer therapy. To val...
Main Authors: | Longhuai Cheng, Liqing Lu, Ziyi Chen, Dejun Ma, Zhen Xi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/20/6943 |
Similar Items
-
“Double-Hit” Chronic Lymphocytic Leukemia, Involving the TP53 and MYC Genes
by: Florence Nguyen-Khac, et al.
Published: (2022-01-01) -
Gene Transactivation and Transrepression in MYC-Driven Cancers
by: Marika Scafuro, et al.
Published: (2021-03-01) -
MYC Causes Multiple Myeloma Progression via Attenuating TP53-Induced MicroRNA-34 Expression
by: Yuki Murakami, et al.
Published: (2022-12-01) -
MYC and therapy resistance in cancer: risks and opportunities
by: Giulio Donati, et al.
Published: (2022-11-01) -
Regulation of IFN-γ-mediated PD-L1 expression by MYC in colorectal cancer with wild-type KRAS and TP53 and its clinical implications
by: Libin Guo, et al.
Published: (2022-12-01)